1、 TOPHURIA D,MATOSHVILI M.Activity after liver resection[J]. Dig Surg,2016,33(1):1-232. TOPHURIA D,MATOSHVILI M.Activity after liver resection[J]. Dig Surg,2016,33(1):1-232.
2、 QU Z,JIANG Y,XU M,et al.Correlation of adrenomedullin with the erythropoietin receptor and microvessel density in hepatocellular carcinoma[J]. Arch Med Sci:AMS,2015,11(5):978-983. QU Z,JIANG Y,XU M,et al.Correlation of adrenomedullin with the erythropoietin receptor and microvessel density in hepatocellular carcinoma[J]. Arch Med Sci:AMS,2015,11(5):978-983.
3、 MUTO J,SHIRABE K,SUGIMACHI K,et al.Review of angiogenesis in hepatocellular carcinoma[J]. Hepatol Res,2015,45(1):1-9. MUTO J,SHIRABE K,SUGIMACHI K,et al.Review of angiogenesis in hepatocellular carcinoma[J]. Hepatol Res,2015,45(1):1-9.
4、 THOMAS S J,SNOWDEN J A,ZEIDLER M P,et al.The role of JAK/STAT signalling in the pathogenesis,prognosis and treatment of solid tumours[J]. Br J Cancer,2015,113(3):365-369. THOMAS S J,SNOWDEN J A,ZEIDLER M P,et al.The role of JAK/STAT signalling in the pathogenesis,prognosis and treatment of solid tumours[J]. Br J Cancer,2015,113(3):365-369.
5、 CHAI H T,YIP H K,SUN C K,et al.AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia[J]. J Inflamm,2016,13(1):18-23. CHAI H T,YIP H K,SUN C K,et al.AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia[J]. J Inflamm,2016,13(1):18-23.
6、 MERKLE R,STEIERT B,SALOPIATA F,et al.Comprehensive modelling of multiple cell types reveals differences in Epo receptor signaling in primary erythroid and lung cancer cells[J]. Pneumol,2015,69(07):A76-A79. MERKLE R,STEIERT B,SALOPIATA F,et al.Comprehensive modelling of multiple cell types reveals differences in Epo receptor signaling in primary erythroid and lung cancer cells[J]. Pneumol,2015,69(07):A76-A79.
7、 TANIGAWA N,AMAYA H,MATSUMURA M,et al.Tumor angiogenesis and mode of metastasis in patients with colorectal cancer[J]. Cancer Res,1997,57(6):1043-1046. TANIGAWA N,AMAYA H,MATSUMURA M,et al.Tumor angiogenesis and mode of metastasis in patients with colorectal cancer[J]. Cancer Res,1997,57(6):1043-1046.
8、 WEIDNER N.Intratumor microvessel density as a prognostic factor in cancer[J]. Am J pathol,1995,147(1):9-11. WEIDNER N.Intratumor microvessel density as a prognostic factor in cancer[J]. Am J pathol,1995,147(1):9-11.
9、 MURAKAMI K,KASAJIMA A,KAWAGISHI N,et al.Microvessel density in hepatocellular carcinoma:prognostic significance and review of the previous published work[J]. Hepatol Res,2015,45(12):1185-1194. MURAKAMI K,KASAJIMA A,KAWAGISHI N,et al.Microvessel density in hepatocellular carcinoma:prognostic significance and review of the previous published work[J]. Hepatol Res,2015,45(12):1185-1194.
10、 V?TSVEEN T K,SPONAAS A M,TIAN E,et al. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro[J]. J Hematol oncol,2016,9(1):75-79. V?TSVEEN T K,SPONAAS A M,TIAN E,et al. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro[J]. J Hematol oncol,2016,9(1):75-79.
11、 ALEMPIJEVIC T,ZEC S,NIKOLIC V,et al.Erythropoietin in predicting prognosis in patients with acute-on-chronic liver failure[J]. J Gastrointest Liver Dis,2016,25(4):54-72. ALEMPIJEVIC T,ZEC S,NIKOLIC V,et al.Erythropoietin in predicting prognosis in patients with acute-on-chronic liver failure[J]. J Gastrointest Liver Dis,2016,25(4):54-72.
12、 MOCCIA F,DRAGONI S,POLETTO V,et al.Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies[J]. Anticancer Agents Med Chem,2014,14(2):296-312. MOCCIA F,DRAGONI S,POLETTO V,et al.Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies[J]. Anticancer Agents Med Chem,2014,14(2):296-312.
13、 BRUIX J,GORES G J,MAZZAFERRO V.Hepatocellular carcinoma:clinical frontiers and perspectives[J]. Gut,2014,63(5):844-855. BRUIX J,GORES G J,MAZZAFERRO V.Hepatocellular carcinoma:clinical frontiers and perspectives[J]. Gut,2014,63(5):844-855.